Long-term Extension Study to Evaluate the Safety of Dutogliptin/PHX1149T in Subjects With Type 2 Diabetes Mellitus

A Study of the Efficacy and Safety of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes

NCT03495102 ·Status: COMPLETED ·Phase: PHASE3

Oral Hypoglycemic Therapy for Monogenic Variant Carriers of the Joslin Medalist Study

NCT04409795 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Comparison Study of the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly Suspension to Sitagliptin and Placebo in Subjects With Type 2 Diabetes Mellitus

NCT01652729 ·Status: COMPLETED ·Phase: PHASE3

30-Week Extension to an Initial Combination Study (24 Weeks in Duration) of Sitagliptin With Pioglitazone (0431-064)

NCT01028391 ·Status: COMPLETED ·Phase: PHASE3

A Phase 3 Study of HS-20094 in Patients With T2DM

NCT07156539 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

Study of Safety and Efficacy of PF-04991532 in Subjects With Type 2 Diabetes

NCT01338870 ·Status: COMPLETED ·Phase: PHASE2

Phase 2 Study To Evaluate Safety And Efficacy Of Investigational Drug - PF04937319 In Patients With Type 2 Diabetes

NCT01475461 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of Lobeglitazone Versus Sitagliptin

NCT02480465 ·Status: UNKNOWN ·Phase: PHASE4

A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus

NCT02597049 ·Status: COMPLETED ·Phase: PHASE3

Study Of Safety And Efficacy Of PF-04991532 In Subjects With Type 2 Diabetes Mellitus

NCT01336738 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of Combination Therapy of Vildagliptin/Metformin in Patients in Type 2 Diabetes Mellitus (T2DM)

NCT01196546 ·Status: COMPLETED ·Phase: PHASE4

A Study to See the Effect of NNC0194-0499 Alone or in Combination With Semaglutide on Blood Sugar Control in People Living With Type 1 Diabetes

NCT07087795 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

Long-term Safety of Alogliptin in Patients With Type 2 Diabetes Mellitus

NCT00306384 ·Status: COMPLETED ·Phase: PHASE3

Study to Evaluate the Long Term Safety and Efficacy of DWP16001 in Patients With Type 2 Diabetes Mellitus

NCT06141980 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

Safety Evaluation of Adverse Reactions in Diabetes

NCT02092597 ·Status: COMPLETED ·Phase: PHASE4

IDG-16177 for the Evaluation of Its Safety and Pharmacokinetics

NCT04982705 ·Status: UNKNOWN ·Phase: PHASE1

Out-Patient Study in Patients With Type 2 Diabetes Mellitus Who Are Taking no Diabetes Medication or Metformin Only

NCT00518115 ·Status: COMPLETED ·Phase: PHASE2

A Study of Sitagliptin in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Diet/Exercise Therapy (0431-054)(COMPLETED)

NCT00411554 ·Status: COMPLETED ·Phase: PHASE3

Effect of DPP4 Inhibition on Growth Hormone Secretion

NCT01701973 ·Status: COMPLETED ·Phase: PHASE4

A Research Study Looking at How Well a Combination of the Medicines Semaglutide and NNC0480-0389 Works in People With Type 2 Diabetes

NCT05144984 ·Status: COMPLETED ·Phase: PHASE2

A Study in Type 2 Diabetics of Single and Multiple Doses of Orally Administered GSK1292263 to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics

NCT01119846 ·Status: COMPLETED ·Phase: PHASE2

Non-Interventional Study on Safety of Liraglutide in Subjects With Type 2 Diabetes

NCT01345734 ·Status: COMPLETED

To Assess Safety of Fixed Dose Combination of Dapagliflozin and Saxagliptin in Type 2 Diabetes Mellitus Patients

NCT04445714 ·Status: COMPLETED ·Phase: PHASE4

Study to Assess the Efficacy and Safety of Sitagliptin in Recently Diagnosed, Naive Type 2 Diabetics With Inadequate Glycemic Control on Diet and Exercise (0431-158)

NCT00832390 ·Status: COMPLETED ·Phase: PHASE4

A Study of an Investigational Drug Sitagliptin for Type 2 Diabetes Mellitus (0431-044)

NCT00127192 ·Status: COMPLETED ·Phase: PHASE2